BIOANALYSIS AND BIOTRANSFORMATION OF OLIGONUCLEOTIDE THERAPEUTICS BY LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY

Mass Spectrom Rev. 2021 Jul;40(4):334-358. doi: 10.1002/mas.21641. Epub 2020 Jun 26.

Abstract

Since 2016, eight new oligonucleotide therapies have been approved which has led to increased interest in oligonucleotide analysis. There is a particular need for powerful bioanalytical tools to study the metabolism and biotransformation of these molecules. This review provides the background on the biological basis of these molecules as currently used in therapies. The article also reviews the current state of analytical methodology including state of the art sample preparation techniques, liquid chromatography-mass spectrometry methods, and the current limits of detection/quantitation. Finally, the article summarizes the challenges in oligonucleotide bioanalysis and provides future perspectives for this emerging field. © 2020 John Wiley & Sons Ltd.

Keywords: oligonucleotide mass spectrometry; oligonucleotide metabolite identification; oligonucleotide quantitation; oligonucleotide sample preparation; oligonucleotide therapeutics.

Publication types

  • Review

MeSH terms

  • Biotransformation
  • Chromatography, Liquid
  • Mass Spectrometry
  • Oligonucleotides*
  • Specimen Handling*

Substances

  • Oligonucleotides